The McGwire inquisition drags on

Leave a comment

Mark McGwire was criticized for years for not saying anything about his steroid use. Now that he’s talking about it to anyone who asks him, Bill Madden of the Daily News slams him for not doing a one-and-done presser like A-Rod and Pettitte did. Oy:

Perhaps, but as far as rehabilitating his image, mere apologies from
McGwire will not suffice – not as long as he continues to maintain that
all the extra power he displayed after ’94 was merely the result of an
altered batting swing and not the steroids. Andy Pettitte in 2008 and Alex Rodriguez last year sat for over an hour, taking their medicine, in the Yankee
pavilion confessional and, for the most part, came out of it for the
better. If nothing else, they’ve been mostly left alone about their
steroid sins from that day forward.

Yeah, remember how Pettitte talked about how that HGH he took gave him all of those extra strikeouts instead of falling back on that tired old “they just helped me stay healthy” lie.  And remember how A-Rod whipped out that chalkboard and drew up that formula which established that he would only have had 437 home runs instead of the 553 he had before last season.  That, my friends, was the kind of candor to which McGwire should aspire.

Madden is a Spink Award winner. I would expect him to be better than this.

Orioles are eying Welington Castillo as their primary catcher target

BALTIMORE, MD - SEPTEMBER 25: Welington Castillo #7 of the Arizona Diamondbacks warms up prior to taking an at bat against the Baltimore Orioles in the second inning at Oriole Park at Camden Yards on September 25, 2016 in Baltimore, Maryland. (Photo by Matt Hazlett/Getty Images)
Getty Images
Leave a comment

A report from the Baltimore Sun’s Dan Connolly suggests that free agent catcher Welington Castillo currently tops the Orioles’ list of potential backstop targets for the 2017 season. With Matt Wieters on the market, the Orioles lack a suitable platoon partner for Caleb Joseph behind the dish, and Connolly adds that the club has been discussing a multi-year deal with Castillo’s representatives since the Winter Meetings.

Castillo batted .264/.322/.423 with the Diamondbacks in 2016, racking up 14 home runs and driving in a career-high 68 RBI in 457 PA. His bat provides much of his upside, and Connolly quoted an anonymous National League scout who believes that the 29-year-old’s defensive profile has fallen short of his potential in recent years.

For better or worse, both the Orioles and Castillo appear far from locking in a deal for 2017. Both the Rays and Braves have expressed interest in the veteran catcher during the past week, while the Orioles are reportedly considering Wieters, Nick Hundley and Chris Iannetta as alternatives behind the plate.

Report: Phillies agree to minor league deal with Daniel Nava

KANSAS CITY, MO - SEPTEMBER 12:  Daniel Nava #12 of the Kansas City Royals bats during the game against the Oakland Athletics at Kauffman Stadium on September 12, 2016 in Kansas City, Missouri.  (Photo by Jamie Squire/Getty Images)
Getty Images
2 Comments

The Phillies reportedly signed veteran outfielder Daniel Nava to a minor league contract, according to Matt Gelb of the Philadelphia Inquirer.

Nava began the season on a one-year contract with the Angels, during which he slashed .235/.309/.303 through 136 PA in the first half of 2016. He was flipped to the Royals in late August for a player to be named later and saw the remainder of his year go down the drain on an .091 average through 12 PA in Anaheim. After getting the boot from the Angels’ 40-man roster in November, the 33-year-old outfielder elected free agency.

Nava is expected to compete for a bench role on the Phillies’ roster in the spring. As it currently stands, the club’s projected 2017 outfield features Howie Kendrick and Odubel Herrera, with precious little depth behind them. Nava’s bat is underwhelming, but at the very least he offers the Phillies a warm body in left field and a potential platoon partner for one of their younger options, a la Tyler Goeddel or Roman Quinn.